QQQ   422.83 (-0.14%)
TSLA   149.20 (-0.49%)
AMD   154.33 (-0.48%)
NIO   3.87 (-3.25%)
BABA   68.49 (-0.57%)
T   16.25 (-0.49%)
MU   109.77 (-1.93%)
GE   152.90 (-0.03%)
CGC   7.60 (-2.94%)
PFE   25.41 (+0.08%)
PYPL   62.02 (-0.13%)
QQQ   422.83 (-0.14%)
TSLA   149.20 (-0.49%)
AMD   154.33 (-0.48%)
NIO   3.87 (-3.25%)
BABA   68.49 (-0.57%)
T   16.25 (-0.49%)
MU   109.77 (-1.93%)
GE   152.90 (-0.03%)
CGC   7.60 (-2.94%)
PFE   25.41 (+0.08%)
PYPL   62.02 (-0.13%)
QQQ   422.83 (-0.14%)
TSLA   149.20 (-0.49%)
AMD   154.33 (-0.48%)
NIO   3.87 (-3.25%)
BABA   68.49 (-0.57%)
T   16.25 (-0.49%)
MU   109.77 (-1.93%)
GE   152.90 (-0.03%)
CGC   7.60 (-2.94%)
PFE   25.41 (+0.08%)
PYPL   62.02 (-0.13%)
QQQ   422.83 (-0.14%)
TSLA   149.20 (-0.49%)
AMD   154.33 (-0.48%)
NIO   3.87 (-3.25%)
BABA   68.49 (-0.57%)
T   16.25 (-0.49%)
MU   109.77 (-1.93%)
GE   152.90 (-0.03%)
CGC   7.60 (-2.94%)
PFE   25.41 (+0.08%)
PYPL   62.02 (-0.13%)

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Roundhill Pro Sports Media & Apparel ETF stock logo
MVP
Roundhill Pro Sports Media & Apparel ETF
$12.33
$12.33
$11.01
$15.00
$4.01MN/A2,002 shsN/A
One Stop Systems, Inc. stock logo
OSS
One Stop Systems
$2.98
+0.7%
$3.24
$1.56
$4.57
$61.87M1.2798,900 shs29,695 shs
Sparton Co. stock logo
SPA
Sparton
$18.51
$18.51
$11.95
$19.77
$181.95M0.53121,970 shs26,459 shs
Terns Pharmaceuticals, Inc. stock logo
TERN
Terns Pharmaceuticals
$4.60
+0.2%
$6.68
$3.26
$14.04
$297.39M-0.63861,931 shs1,528 shs
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Roundhill Pro Sports Media & Apparel ETF stock logo
MVP
Roundhill Pro Sports Media & Apparel ETF
0.00%0.00%0.00%0.00%-0.04%
One Stop Systems, Inc. stock logo
OSS
One Stop Systems
+0.68%-6.88%-18.13%+53.61%+20.16%
Sparton Co. stock logo
SPA
Sparton
0.00%0.00%0.00%0.00%0.00%
Terns Pharmaceuticals, Inc. stock logo
TERN
Terns Pharmaceuticals
+1.10%-12.07%-23.75%-5.56%-65.20%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Roundhill Pro Sports Media & Apparel ETF stock logo
MVP
Roundhill Pro Sports Media & Apparel ETF
N/AN/AN/AN/AN/AN/AN/AN/A
One Stop Systems, Inc. stock logo
OSS
One Stop Systems
1.4128 of 5 stars
3.23.00.00.01.80.80.6
Sparton Co. stock logo
SPA
Sparton
N/AN/AN/AN/AN/AN/AN/AN/A
Terns Pharmaceuticals, Inc. stock logo
TERN
Terns Pharmaceuticals
3.411 of 5 stars
3.41.00.04.11.53.30.0

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Roundhill Pro Sports Media & Apparel ETF stock logo
MVP
Roundhill Pro Sports Media & Apparel ETF
0.00
N/AN/AN/A
One Stop Systems, Inc. stock logo
OSS
One Stop Systems
2.40
Hold$4.0636.33% Upside
Sparton Co. stock logo
SPA
Sparton
N/AN/AN/AN/A
Terns Pharmaceuticals, Inc. stock logo
TERN
Terns Pharmaceuticals
2.75
Moderate Buy$14.94224.73% Upside

Current Analyst Ratings

Latest GETB, TERN, SPA, OSS, and MVP Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/27/2024
Terns Pharmaceuticals, Inc. stock logo
TERN
Terns Pharmaceuticals
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$19.00 ➝ $18.00
3/22/2024
One Stop Systems, Inc. stock logo
OSS
One Stop Systems
Benchmark
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$3.00 ➝ $5.00
3/22/2024
One Stop Systems, Inc. stock logo
OSS
One Stop Systems
Roth Mkm
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$5.00 ➝ $5.50
3/18/2024
Terns Pharmaceuticals, Inc. stock logo
TERN
Terns Pharmaceuticals
JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$17.00 ➝ $15.00
3/15/2024
Terns Pharmaceuticals, Inc. stock logo
TERN
Terns Pharmaceuticals
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral$5.50
3/15/2024
Terns Pharmaceuticals, Inc. stock logo
TERN
Terns Pharmaceuticals
BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$18.00 ➝ $19.00
(Data available from 4/19/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Roundhill Pro Sports Media & Apparel ETF stock logo
MVP
Roundhill Pro Sports Media & Apparel ETF
N/AN/AN/AN/AN/AN/A
One Stop Systems, Inc. stock logo
OSS
One Stop Systems
$60.90M1.02N/AN/A$1.92 per share1.55
Sparton Co. stock logo
SPA
Sparton
$374.99M0.49$2.90 per share6.38$7.67 per share2.41
Terns Pharmaceuticals, Inc. stock logo
TERN
Terns Pharmaceuticals
$1M297.39N/AN/A$4.13 per share1.11

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Roundhill Pro Sports Media & Apparel ETF stock logo
MVP
Roundhill Pro Sports Media & Apparel ETF
N/AN/A0.00N/AN/AN/AN/AN/A
One Stop Systems, Inc. stock logo
OSS
One Stop Systems
-$6.72M-$0.33N/AN/AN/A-11.03%-10.09%-7.89%5/9/2024 (Estimated)
Sparton Co. stock logo
SPA
Sparton
-$8.25MN/A14.76N/A0.63%16.80%5.41%N/A
Terns Pharmaceuticals, Inc. stock logo
TERN
Terns Pharmaceuticals
-$90.21M-$1.27N/AN/AN/AN/A-33.55%-31.90%5/20/2024 (Estimated)

Latest GETB, TERN, SPA, OSS, and MVP Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
3/21/2024Q4 2023
One Stop Systems, Inc. stock logo
OSS
One Stop Systems
-$0.06-$0.01+$0.05-$0.01$13.00 million$13.16 million
3/14/2024Q4 2023
Terns Pharmaceuticals, Inc. stock logo
TERN
Terns Pharmaceuticals
-$0.29-$0.29N/A-$0.29N/AN/A

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Roundhill Pro Sports Media & Apparel ETF stock logo
MVP
Roundhill Pro Sports Media & Apparel ETF
N/AN/AN/AN/AN/A
One Stop Systems, Inc. stock logo
OSS
One Stop Systems
N/AN/AN/AN/AN/A
Sparton Co. stock logo
SPA
Sparton
N/AN/AN/AN/AN/A
Terns Pharmaceuticals, Inc. stock logo
TERN
Terns Pharmaceuticals
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Roundhill Pro Sports Media & Apparel ETF stock logo
MVP
Roundhill Pro Sports Media & Apparel ETF
N/AN/AN/A
One Stop Systems, Inc. stock logo
OSS
One Stop Systems
N/A
6.18
3.02
Sparton Co. stock logo
SPA
Sparton
N/A
0.99
0.39
Terns Pharmaceuticals, Inc. stock logo
TERN
Terns Pharmaceuticals
N/A
22.39
22.39

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Roundhill Pro Sports Media & Apparel ETF stock logo
MVP
Roundhill Pro Sports Media & Apparel ETF
N/A
One Stop Systems, Inc. stock logo
OSS
One Stop Systems
32.67%
Sparton Co. stock logo
SPA
Sparton
74.88%
Terns Pharmaceuticals, Inc. stock logo
TERN
Terns Pharmaceuticals
98.26%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Roundhill Pro Sports Media & Apparel ETF stock logo
MVP
Roundhill Pro Sports Media & Apparel ETF
N/A325,000N/ANot Optionable
One Stop Systems, Inc. stock logo
OSS
One Stop Systems
9620.76 million19.10 millionNot Optionable
Sparton Co. stock logo
SPA
Sparton
1,5319.83 millionN/AOptionable
Terns Pharmaceuticals, Inc. stock logo
TERN
Terns Pharmaceuticals
6664.65 million53.40 millionNot Optionable

GETB, TERN, SPA, OSS, and MVP Headlines

SourceHeadline
Terns Pharmaceuticals Inc Ordinary SharesTerns Pharmaceuticals Inc Ordinary Shares
morningstar.com - April 18 at 6:23 PM
Intra-Cellular depression data has investors feeling goodIntra-Cellular depression data has investors feeling good
thepharmaletter.com - April 17 at 3:21 PM
Kumquat Biosciences joins forces with Takeda on I-O developmentKumquat Biosciences joins forces with Takeda on I-O development
thepharmaletter.com - April 17 at 3:21 PM
Terns Pharmaceuticals, Inc.: Terns Pharmaceuticals Appoints Melita Sun Jung as Chief Business OfficerTerns Pharmaceuticals, Inc.: Terns Pharmaceuticals Appoints Melita Sun Jung as Chief Business Officer
finanznachrichten.de - April 11 at 8:35 AM
Terns Pharmaceuticals Appoints Melita Sun Jung as Chief Business OfficerTerns Pharmaceuticals Appoints Melita Sun Jung as Chief Business Officer
globenewswire.com - April 10 at 4:05 PM
Madrigal announces US launch of NASH/MASH drug RezdiffraMadrigal announces US launch of NASH/MASH drug Rezdiffra
msn.com - April 9 at 10:28 AM
Vivo Capital entities sell Terns Pharmaceuticals shares worth $2.8 millionVivo Capital entities sell Terns Pharmaceuticals shares worth $2.8 million
investing.com - April 5 at 10:17 AM
Vivo Opportunity, Llc Sells 138,066 Shares of Terns Pharmaceuticals, Inc. (NASDAQ:TERN) StockVivo Opportunity, Llc Sells 138,066 Shares of Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Stock
insidertrades.com - April 5 at 5:24 AM
Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Major Shareholder Vivo Opportunity, Llc Sells 181,117 SharesTerns Pharmaceuticals, Inc. (NASDAQ:TERN) Major Shareholder Vivo Opportunity, Llc Sells 181,117 Shares
insidertrades.com - April 4 at 6:15 AM
This small-cap stock is expected to take off - if its weight-loss pill trial succeedsThis small-cap stock is expected to take off - if its weight-loss pill trial succeeds
morningstar.com - March 30 at 7:03 PM
This small-cap stock is expected to take off — if its weight-loss pill trial succeedsThis small-cap stock is expected to take off — if its weight-loss pill trial succeeds
marketwatch.com - March 28 at 3:24 PM
UBS Group Lowers Terns Pharmaceuticals (NASDAQ:TERN) Price Target to $18.00UBS Group Lowers Terns Pharmaceuticals (NASDAQ:TERN) Price Target to $18.00
marketbeat.com - March 27 at 3:09 PM
Here’s Why Ozempic And Mounjaro Rivals Won’t Topple Weight Loss Drugmakers Novo Nordisk And Eli Lilly Anytime SoonHere’s Why Ozempic And Mounjaro Rivals Won’t Topple Weight Loss Drugmakers Novo Nordisk And Eli Lilly Anytime Soon
msn.com - March 27 at 9:31 AM
Wall Streets Favorite Biotech Stocks? 3 Names That Could Make You Filthy RichWall Street's Favorite Biotech Stocks? 3 Names That Could Make You Filthy Rich
investorplace.com - March 25 at 3:00 PM
Optimistic Buy Rating for Terns Pharmaceuticals Based on Strong Clinical Pipeline and Financial StabilityOptimistic Buy Rating for Terns Pharmaceuticals Based on Strong Clinical Pipeline and Financial Stability
markets.businessinsider.com - March 21 at 6:49 AM
TERN Apr 2024 15.000 callTERN Apr 2024 15.000 call
finance.yahoo.com - March 16 at 1:45 PM
Terns Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate UpdatesTerns Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Updates
globenewswire.com - March 14 at 4:05 PM
Terns Pharmaceuticals, Inc.: Terns Pharmaceuticals Announces Orphan Drug Designation Granted to TERN-701 for the Treatment of Chronic Myeloid LeukemiaTerns Pharmaceuticals, Inc.: Terns Pharmaceuticals Announces Orphan Drug Designation Granted to TERN-701 for the Treatment of Chronic Myeloid Leukemia
finanznachrichten.de - March 12 at 4:18 AM
Terns Pharmaceuticals Announces Orphan Drug Designation Granted to TERN-701 for the Treatment of Chronic Myeloid LeukemiaTerns Pharmaceuticals Announces Orphan Drug Designation Granted to TERN-701 for the Treatment of Chronic Myeloid Leukemia
globenewswire.com - March 11 at 4:05 PM
Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)
globenewswire.com - March 7 at 4:05 PM
Terns Pharmaceuticals to Participate in Upcoming March Investor ConferencesTerns Pharmaceuticals to Participate in Upcoming March Investor Conferences
globenewswire.com - February 27 at 4:05 PM
Terns Pharmaceuticals, Inc.: Terns Pharmaceuticals Reports Inducement Grants to New Chief Executive Officer Under Nasdaq Listing Rule 5635(C)(4)Terns Pharmaceuticals, Inc.: Terns Pharmaceuticals Reports Inducement Grants to New Chief Executive Officer Under Nasdaq Listing Rule 5635(C)(4)
finanznachrichten.de - February 9 at 9:57 AM
Terns Pharmaceuticals, Inc.: Terns Pharmaceuticals Appoints Amy Burroughs as Chief Executive OfficerTerns Pharmaceuticals, Inc.: Terns Pharmaceuticals Appoints Amy Burroughs as Chief Executive Officer
finanznachrichten.de - February 7 at 5:40 PM
Terns Pharmaceuticals Reports Inducement Grants to New Chief Executive Officer Under Nasdaq Listing Rule 5635(C)(4)Terns Pharmaceuticals Reports Inducement Grants to New Chief Executive Officer Under Nasdaq Listing Rule 5635(C)(4)
finance.yahoo.com - February 7 at 5:40 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Roundhill Pro Sports Media & Apparel ETF logo

Roundhill Pro Sports Media & Apparel ETF

NYSEARCA:MVP
One Stop Systems logo

One Stop Systems

NASDAQ:OSS
One Stop Systems, Inc. engages in the design, manufacture, and marketing of high-performance compute, high speed storage hardware and software, switch fabrics, and systems for edge deployments in the United States and internationally. The company's systems are built using the central processing unit, graphical processing unit and high-speed switch fabrics and flash storage technologies. It provides custom servers, data acquisition platforms, compute accelerators, solid-state storage arrays, PCIe expansion products, and system I/O expansion systems, as well as edge optimized industrial and panel PCs, tablets, and handheld compute devices. The company also offers ruggedized mobile tablets and handhelds that meet the specialized requirement for devices deployed at the edge in a diverse set of environmental conditions. It sells its products to multinational companies, governmental agencies, military contractors, military services, and technology providers through its website, web store, direct sales team, and original equipment manufacturer focused sales, as well as through a network of resellers and distributors. The company was founded in 1998 and is headquartered in Escondido, California.
Sparton logo

Sparton

NYSE:SPA
Sparton Corporation, together with its subsidiaries, provides design, development, and manufacturing services for electromechanical devices; and engineered products in electromechanical value stream worldwide. The company operates through two segments, Manufacturing & Design Services (MDS), and Engineered Components & Products (ECP). The MDS segment is involved in the contract design, manufacture, and aftermarket repair and refurbishment of printed circuit card assemblies, sub-assemblies, full product assemblies, and cable/wire harnesses, as well as development of embedded software and software quality assurance services in connection with medical devices and diagnostic equipment. This segment serves original equipment manufacturers and emerging technology customers serving the medical and biotechnology, military and aerospace, and industrial and commercial markets. The ECP segment designs, develops, and produces proprietary products for domestic and foreign defense, and commercial applications. It offers anti-submarine warfare devices for the U.S. Navy and foreign governments; rugged flat panel display systems for military panel PC workstations, air traffic control and industrial, and commercial marine applications; and high performance industrial grade computer systems and peripherals, as well as develops and markets commercial products for underwater acoustics and microelectromechanical based inertial measurement. This segment also performs an engineering development function for the United States military and prime defense contractors. Sparton Corporation was founded in 1900 and is headquartered in Schaumburg, Illinois.
Terns Pharmaceuticals logo

Terns Pharmaceuticals

NASDAQ:TERN
Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule product candidates for the treatment of oncology, metabolic dysfunction-associated steatohepatitis (MASH), and obesity. The company develops TERN-701, an allosteric BCR-ABL tyrosine kinase inhibitor (TKI) that is in phase 1 clinical trial for chronic myeloid leukemia (CML), a form of cancer that starts in bone marrow. It also develops TERN-501, a thyroid hormone receptor beta agonist with enhanced liver distribution and metabolic stability that is in Phase IIa clinical trial for the treatment of MASH; and TERN-601, a small-molecule Glucagon-Like Peptide-1 receptor agonist program that is intended to orally be administered for obesity. The company was incorporated in 2016 and is headquartered in Foster City, California.